A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus

Neurosurgery

Volumn 45, Issue 6, 1999, Pages 1399-1411

  Pollack, Ian F ^a   Albright, A Leland ^a   Adelson, P David ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Cerebrospinal fluid; Hydrocephalus; Outcome; Programmable; Randomized study; Shunt

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; EXPLANT; FEMALE; FOLLOW UP; HUMAN; HYDROCEPHALUS; IMPLANTATION; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHUNTING; SURGICAL INSTRUMENT; TREATMENT OUTCOME;

EID: 0032764025     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199912000-00026     Document Type: Article

References (53)

1. Albright AL, Haines SJ, Taylor FH: Function of parietal and frontal shunts in childhood hydrocephalus. J Neurosurg 69:883-886, 1988.
2. Aschoff A, Kremer P, Benesch C, Fruh K, Klank A, Kunze S: Overdrainage and shunt technology: A critical comparison of programmable, hydrostatic and variable-resistance valves and flow-reducing devices. Childs Nerv Syst 11:193-202, 1995.
3. Belliard H, Roux FX, Turak B, Nataf F, Devaux B, Cioloca C: The Codman Medos programmable shunt valve: Evaluation of 53 implantations in 50 patients [in French]. Neurochirurgie 42:139-146, 1996.
4. Bierbrauer KS, Storrs BB, McLone DG, Tomita T, Dauser R: A prospective, randomized study of shunt function and infections as a function of shunt placement. Pediatr Neurosurg 16:287-291, 1990-1991.
5. Black PMcL, Hakim R, Bailey NO: The use of the Codman-Medos programmable Hakim valve in the management of patients with hydrocephalus: Illustrative cases. Neurosurgery 34:1110-1113, 1994.
6. Bondurant CP, Jimenez DF: Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 23:254-259, 1995.
7. Boon AJ, Tans JT, Delvel EJ, Egeler-Peerdeman SM, Hanlo PW, Wurzer HA, Avezaat CJ, de Jong DA, Gooskens RH, Hermans J: Dutch Normal-Pressure Hydrocephalus Study: Randomized comparison of low- and medium-pressure shunts. J Neurosurg 88:490-495, 1998.
8. Caldarelli M, Di Rocco C, La Marca F: Shunt complications in the first postoperative year in children with myelomeningocele. Childs Nerv Syst 12:748-754, 1996.
9. Chapman PH, Cosman ER, Arnold MA: The relationship between ventricular fluid pressure and body position in normal subjects and subjects with shunts: A telemetric study. Neurosurgery 26: 181-189, 1990.
10. Cozzens JW, Chandler JP: Increased risk of distal ventriculoperitoneal shunt obstruction associated with slit valves or distal slits in the peritoneal catheter. J Neurosurg 87:682-686, 1997.
11. Czosnyka Z, Czosnyka M, Richards HK, Pickard JD: Posture-related overdrainage: Comparison of the performance of 10 hydrocephalus shunts in vitro. Neurosurgery 42:327-334, 1998.
12. Di Rocco C, Marchese E, Velardi F: A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus: Cooperative survey of the 1991-1992 Education Committee of the ISPN. Childs Nerv Syst 10:321-327, 1994.
13. Drake JM, Kestle J: Rationale and methodology of the multicenter pediatric cerebrospinal fluid shunt design trial: Pediatric Hydrocephalus Treatment Evaluation Group. Childs Nerv Syst 12:434-447, 1996.
14. Drake JM, da Silva MC, Rutka JT: Functional obstruction of an antisiphon device by raised tissue capsule pressure. Neurosurgery 32:137-139, 1993.
15. Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J Jr, Haines S, Schiff SJ, Cochrane DD, Steinbok P, MacNeil N: Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 43:294-305, 1998.
16. Elshoff JD: Query Advisor User's Guide. Los Angeles, Dixon Associates, 1995.
17. Fransen P: Transcutaneous pressure-adjustable valves and magnetic resonance imaging: An ex vivo examination of the Codman-Medos programmable valve and the Sophy adjustable pressure valve. Neurosurgery 42:430, 1998 (comment).
18. Fransen P, Dooms G, Thauvoy C: Safety of the adjustable pressure ventricular valve in magnetic resonance imaging: Problems and solutions. Neuroradiology 34:508-509, 1992.
19. Griebel R, Kahn M, Tan L: CSF shunt complications: An analysis of contributory factors. Childs Nerv Syst 1:77-80, 1985.
20. Gruber R, Jenny P, Herzog B: Experiences with the anti-siphon device (ASD) in shunt therapy of pediatric hydrocephalus. J Neurosurg 61:156-162, 1984.
21. Hassan M, Higashi S, Yamashita J: Risks in using siphon-reducing devices in adult patients with normal-pressure hydrocephalus: Bench test investigations with Delta valves. J Neurosurg 84:634-641, 1996.
22. Horton D, Pollay M: Fluid flow performance of a new siphon-control device for ventricular shunts. J Neurosurg 72:926-932, 1990.
23. Izumihara A, Orita T, Tsurutani T, Kajiwara K: Shunting operation with the Medos programmable valve shunt system [in Japanese]. No Shinkei Geka 22:731-735, 1994.
24. Kamano S, Nakano Y, Imanishi T, Hattori M: Management with a programmable pressure valve of subdural hematomas caused by a ventriculoperitoneal shunt: Case report. Surg Neurol 35:381-383, 1991.
25. Kamiryo T, Fujii Y, Kusaka M, Kashiwagi S, Ito H: Intracranial pressure monitoring using a programmable pressure valve and a telemetric intracranial pressure sensor in a case of slit ventricle syndrome after multiple shunt revisions. Childs Nerv Syst 7:233-234, 1991.
26. Kikuchi K, Kowada M, Sasaki J, Watanabe K, Sasajima H, Yoneya M: Ventriculoperitoneal shunts with the use of pressure-adjustable valve in the management of hydrocephalus [in Japanese]. No Shinkei Geka 18:241-246, 1990.
27. Laurence KM: Neurological and intellectual sequelae of hydrocephalus. Arch Neurol 20:73-81, 1969.
28. Liptak GS, McDonald JV: Ventriculoperitoneal shunts in children: Factors affecting shunt survival. Pediatr Neurosci 12:289-293, 1986.
29. Lumenta CB, Skotarczak U: Long-term follow-up in 233 patients with congenital hydrocephalus. Childs Nerv Syst 11:173-175, 1995.
30. Lumenta CB, Roosen N, Dietrich U: Clinical experience with a pressure-adjustable Sophy valve in the management of hydrocephalus. Childs Nerv Syst 3:270-274, 1990.
31. Major O, Fedorcsak I, Sipos L, Hantos P, Konye E, Dobronyi I, Paraicz E: Slit-ventricle syndrome in shunt operated children. Acta Neurochir (Wien) 127:69-72, 1994.
32. Matsumae M, Sato O, Itoh K, Fukuda T, Suzuki Y: Quantification of cerebrospinal fluid shunt flow rates: Assessment of the programmable pressure adjustable valve. Childs Nerv Syst 5:356-360, 1989.
33. O'Reilly G, Williams B: The Sophy valve and the el-Shafei shunt system for adult hydrocephalus. J Neurol Neurosurg Psychiatry 59:621-624, 1995.
34. Ortler M, Kostron H, Felber S: Transcutaneous pressure-adjustable valves and magnetic resonance imaging: An ex vivo examination of the Codman-Medos programmable valve and the Sophy adjustable pressure valve. Neurosurgery 40:1050-1058, 1997.
35. Piatt JH Jr: Cerebrospinal fluid shunt failure: Late is different than early. Pediatr Neurosurg 23:133-139, 1995.
36. Piatt JH Jr, Carlson CV: A search for determinants of cerebrospinal fluid shunt survival: A retrospective analysis of a 14-year institutional experience. Pediatr Neurosurg 19:233-242, 1993.
37. Portnoy HD, Schulte RR, Fox JL, Croissant PD, Tripp L: Antisiphon and reversible occlusion valves for shunting in hydrocephalus and preventing post-shunt subdural hematomas. J Neurosurg 38:729-738, 1973.
38. Puca A, Anile C, Maira G, Rossi G: Cerebrospinal fluid shunting for hydrocephalus in the adult: Factors related to shunt revision. Neurosurgery 29:822-826, 1991.
39. Reinprecht A, Czech T, Dietrich W: Clinical experience with a new pressure-adjustable shunt valve. Acta Neurochir (Wien) 134: 119-124, 1995.
40. Reinprecht A, Dietrich W, Bertalanffy A, Czech T: The Medos Hakim programmable valve in the treatment of pediatric hydrocephalus. Childs Nerv Syst 13:588-594, 1997.
41. Rekate HL: Does it matter which shunt is used? Crit Rev Neurosurg 6:53-57, 1996.
42. Sainte-Rose C: Shunt obstruction: A preventable complication? Pediatr Neurosurg 19:156-164, 1993.
43. Sainte-Rose C, Hooven MD, Hirsch JF: A new approach in the treatment of hydrocephalus. J Neurosurg 66:213-226, 1987.
44. Sainte-Rose C, Piatt JH, Renier D, Pierre-Kahn A, Hirsch JF, Hoffman HJ, Humphreys RP, Hendrick EB: Mechanical complications in shunts. Pediatr Neurosurg 17:2-9, 1991-1992.
45. Sgouros S, Malluci C, Walsh AR, Hockley AD: Long-term complications of hydrocephalus. Pediatr Neurosurg 23:127-132, 1995.
46. Sindou M, Guyotat-Pelissou I, Chidiac A, Goutelle A: Transcutaneous pressure adjustable valve for the treatment of hydrocephalus and arachnoid cysts in adults: Experience with 75 cases. Acta Neurochir (Wien) 121:135-139, 1993.
47. Steinbok P, Boyd M, Flodmark CO, Cochrane DD: Radiographic imaging requirements following ventriculoperitoneal shunt procedures. Pediatr Neurosurg 22:141-146, 1995.
48. Steinbok P, Irvine B, Cochrane DD, Irwin BJ: Long-term outcome and complications of children born with meningomyelocele. Childs Nerv Syst 8:92-96, 1992.
49. Sutcliffe JC, Battersby RD: Do we need variable pressure shunts? Br J Neurosurg 6:67-70, 1992.
50. Trost HA, Hiessler HE, Classmer G, Gaab MR: Testing the hydrocephalus shunt valve: Long-term bench test results of various new and explanted valves - The need for model for testing valves under physiological conditions. Eur J Pediatr Surg 1[Suppl I]:38-40, 1991.
51. Walker G: Statistical Methods for Clinical Research. San Diego, Collins-Wellesley Publishing, 1996.
52. Walker M, Fried A, Petronio J: Diagnosis and treatment of the slit ventricle syndrome. Neurosurg Clin N Am 4:707-714, 1993.
53. Zemack G, Romner B: Five years of clinical experience with the programmable Medos valve: 428 implanted valves in 388 patients, in Proceedings of the Annual Meeting of the Congress of Neurological Surgeons, New Orleans, 1997, p 170.